## Abstract ## Objective To investigate whether circulating levels of soluble tumor necrosis factor receptors (sTNFR) are predictive of mortality in rheumatoid arthritis (RA). ## Methods Levels of sTNFRI and sTNFRII at study entry were quantified using enzyme‐linked immunosorbent assays in sera
✦ LIBER ✦
Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor α, and interleukin-6 levels in rheumatoid arthritis.
✍ Scribed by Pilar Barrera; Agnes M. Th. Boerbooms; Elly M. Janssen; Robert W. Sauerwein; H. Gallati; Jan Mulder; Theo De Boo; Pierre N. M. Demacker; Levinus B. A. Van De Putte; JOS W. M. Van Der Meer
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 839 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Circulating levels of tumor necrosis fac
✍
Derek L. Mattey; John R. Glossop; Nicola B. Nixon; Peter T. Dawes
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 138 KB
👁 2 views
Soluble human p55 and p75 tumor necrosis
✍
Carl K. Edwards III; Alison M. Bendele; Leonid I. Reznikov; Giamila Fantuzzi; El
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
English
⚖ 808 KB
Association between rheumatoid arthritis
✍
Anne Barton; Sally John; W. E. R. Ollier; Alan Silman; Jane Worthington
📂
Article
📅
2001
🏛
John Wiley and Sons
🌐
English
⚖ 61 KB
👁 2 views
Interleukin-6 receptor shedding is enhan
✍
Nathalie Franchimont; Cécile Lambert; Pascale Huynen; Clio Ribbens; Biserka Reli
📂
Article
📅
2005
🏛
John Wiley and Sons
🌐
English
⚖ 300 KB
👁 1 views
Interleukin-1, Interleukin-2, Interleuki
✍
Barbara White Needleman; Fredrick M. Wigley; Richard W. Stair
📂
Article
📅
1992
🏛
John Wiley and Sons
🌐
English
⚖ 467 KB
👁 1 views
Modulation of angiogenic vascular endoth
✍
Ewa M. Paleolog; Sylvia Young; Alison C. Stark; Richard V. McCloskey; Marc Feldm
📂
Article
📅
1998
🏛
John Wiley and Sons
🌐
English
⚖ 804 KB
## Objective: To investigate the regulation of expression of the angiogenic cytokine vascular endothelial growth factor (vegf) in rheumatoid arthritis (ra), in order to determine whether new blood vessel formation could be a potential therapeutic target in ra. ## Methods: Dissociated ra synovial